Dynamic estimation of cardiac repolarization characteristics during hypoglycemia in healthy and diabetic subjects

By Lipponen J A   Kemppainen J   Karjalainen P A   Laitinen T   Mikola H   Kärki T   Tarvainen M P  

Physiological Measurement, Vol. 32, Iss. 6, 2011-06 ,pp. : 649-660

IOP Publishing

Access to resources Recommend Favorite

Safety, tolerability and pharmacokinetics of escalating doses of NXY-059 in healthy young and elderly subjects

By Wemer Johan   Cheng Yi-Fang   Nilsson Dag   Reinholdsson Ingalill   Fransson Bo   Lanbeck Vallén Kerstin   Nyman Lars   Eriksson Catarina   Björck Staffan   Schulman Sam  

Current Medical Research and Opinion, Vol. 22, Iss. 9, 2006-09 ,pp. : 1813-1823

Informa Healthcare

Access to resources Recommend Favorite

Pharmacokinetics, pharmacodynamics, safety, and tolerability of pradigastat, a novel diacylglycerol acyltransferase 1 inhibitor in overweight or obese, but otherwise healthy human subjects

By  

JOURNAL OF CLINICAL PHARMACOLOGY (ELECTRONIC), Vol. 55, Iss. 9, 2015-09 ,pp. : 1031-1041

John Wiley & Sons Inc

Access to resources Recommend Favorite

Randomised clinical trial: safety, tolerability, pharmacokinetics and pharmacodynamics of repeated doses of TAK‐438 (vonoprazan), a novel potassium‐competitive acid blocker, in healthy male subjects

By  

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol. 41, Iss. 7, 2015-04 ,pp. : 636-648

John Wiley & Sons Inc

Access to resources Recommend Favorite

A phase I trial assessing the safety, tolerability, pharmacokinetic and pharmacodynamic characteristics of single‐dose Auron Misheil therapy in healthy male subjects

By  

JOURNAL OF CLINICAL PHARMACY & THERAPEUTICS, Vol. 38, Iss. 1, 2013-02 ,pp. : 3-11

John Wiley & Sons Inc

Access to resources Recommend Favorite